HUM vs JBIO · P/E 39, rev $129.66B vs $868.2M cap
Humana Inc (HUM) versus Jade Biosciences, Inc. (JBIO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Jade Biosciences, Inc. (JBIO) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
JBIO does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. JBIO currently screens at market cap $868.2M.
Not investment advice. Open the HUM and JBIO stock pages for the full models.
Not investment advice.